Description
Mounjaro 5 mg (Tirzepatide Injection) – Dual Incretin Therapy for Type 2 Diabetes
Mounjaro (Tirzepatide) 5 mg is an innovative, once-weekly injectable medication for adults with type 2 diabetes. It works as a dual GIP and GLP-1 receptor agonist to help regulate blood sugar, support insulin sensitivity, and promote weight loss. Manufactured by Eli Lilly, Mounjaro is FDA-approved for glycemic control in patients with type 2 diabetes and is administered via a prefilled injection pen.
Key Benefits:
- Improves glycemic control in adults with type 2 diabetes
- Supports significant weight loss in many patients (off-label use)
- Once-weekly subcutaneous injection
- Dual action on GIP and GLP-1 receptors
- May reduce risk of cardiovascular complications
How to Use:
Administer one subcutaneous injection of 5 mg once weekly in the abdomen, thigh, or upper arm. Rotate injection sites with each dose. Follow your healthcare provider’s instructions carefully.
Precautions:
- Not for use in patients with type 1 diabetes or diabetic ketoacidosis
- Use caution in patients with a history of pancreatitis
- Not recommended during pregnancy or breastfeeding
- May interact with oral medications—consult your doctor
Storage Instructions:
Store refrigerated at 2°C–8°C (36°F–46°F). Do not freeze. Once removed from refrigeration, it can be kept at room temperature for up to 21 days.
Frequently Asked Questions (FAQs)
1. What is Mounjaro used for?
Mounjaro (Tirzepatide) is approved for the treatment of type 2 diabetes and helps control blood sugar levels. It also shows weight loss benefits in many patients.
2. How is Mounjaro 5 mg administered?
It is a once-weekly subcutaneous injection, typically given in the thigh, abdomen, or upper arm using a prefilled pen.
3. Is Mounjaro approved for weight loss?
No, Mounjaro is FDA-approved for type 2 diabetes. However, it has shown weight loss effects in clinical trials, and doctors may prescribe it off-label for this purpose.
4. What are the common side effects?
Common side effects include nausea, diarrhea, decreased appetite, constipation, and vomiting. Serious side effects include pancreatitis and kidney issues—seek immediate medical attention if symptoms arise.
5. Can I use Mounjaro if I’m on insulin?
Mounjaro can be used with or without insulin but requires close monitoring to avoid hypoglycemia. Always consult your healthcare provider.
